SCN2A and Cognitive impairment: The expression of Nav1.2 is increased in the hippocampus and cortex of chronic cerebral hypoperfusion model rat, while repression of the increased expression of Nav1.2 improves neuropathological and cognitive impairment (Hu et al., 2019).